CELUW vs PSA · rev $54.2M vs rev $1.23B
Celularity Inc (CELUW) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Celularity Inc (CELUW) common stock listed on US.
PSA (PSA) common stock.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
CELUW currently screens at market cap $0. PSA currently screens at market cap $0.
Not investment advice. Open the CELUW and PSA stock pages for the full models.
Not investment advice.